NCT07109128

Brief Summary

Despite recent technological advances in type 1 diabetes (T1D) treatment, adolescents are the only age group for which glycemic levels have not improved. Technology and education help adolescents execute the mechanics of managing blood glucose levels, but do not help adolescents manage the emotional distress that arises when T1D management goals conflict with social/emotional goals (e.g., taking insulin for a meal in front of new friends vs. trying to "fit-in"). The emotional distress caused by such situations can be difficult to manage and can lead to unhealthy risk behaviors and disengagement in T1D self-management (e.g., deciding to skip a lunch-time bolus to avoid bolusing in front of new friends). A novel approach in T1D research is to target emotions directly by promoting emotion regulation skills. In the general population, emotion regulation interventions have demonstrated success in preventing both unhealthy behaviors and mood disorders among younger adolescents, including younger adolescents with social-emotional risk-factors like low SES. The investigators' scientific premise is that an emotion regulation intervention for younger adolescents with T1D (age 12-14) could promote skills to help youth manage emotional burdens of living with T1D, reduce unhealthy and risky T1D self-management behaviors, and prevent unhealthy patterns of behaviors and distress/mood disorders that often appear in later adolescence. Using the ORBIT Model, a systematic framework for developing behavioral interventions for people with chronic diseases, the investigators adapted an evidence-based, manualized emotion regulation intervention for young adolescents, so that it is relevant for youth with T1D. The current study is a natural extension of this previous work. For the current study, the investigators propose to complete a feasibility and acceptability trial of this novel emotion regulation intervention for youth with T1D. The investigators aimed to pilot the novel emotion regulation intervention (11 virtual group sessions) with 3 sequential groups of 6-8 young adolescents (age 12-14) with T1D in each group and obtain feedback from facilitators and participants and their parents after each session, and after the intervention.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 23, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 7, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 14, 2025

Completed
Last Updated

August 7, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

April 23, 2025

Last Update Submit

July 30, 2025

Conditions

Keywords

adolescentsemotion regulationgroupvirtual

Outcome Measures

Primary Outcomes (3)

  • Percent of participants who attended the intervention

    Feasibility will be demonstrated by average individual participation in at least 70% of the sessions, and \>70% of participants completing the intervention by participating in the last session.

    Through study completion, up to 12 weeks

  • Percent of participants who rated each session as acceptable

    The percentage of participants who rated each session as "acceptable" on a post-session survey rating scales that were developed for this study. 6 items on the session evaluation survey assess the following: relevance, trust in the information, ease of understanding, learning novel information, and interest in topics. Item responses include a 5-point Likert scale from "strongly disagree to strongly agree". The research team will average participant's responses across the items, thus total score could be a minimum of 1 and a maximum of 5, with a higher score indicating higher acceptability of the intervention. The intervention will be considered acceptable if ≥ 70% of participants rate each session as acceptable, as indicated by a total score \>3.

    Through study completion, up to 12 weeks

  • Percent of participants who rated the overall intervention as acceptable

    The percentage of participants who rated the intervention, as a whole, as "acceptable" on a post-intervention survey rating scales that were developed for this study. 16 items on the intervention evaluation survey assess, one's perceptions of the intervention. Item responses include a 5-point Likert scale from "strongly disagree to strongly agree". The research team will reverse score items that negatively worded and average participant's responses across the items, thus total score could be a minimum of 1 and a maximum of 5, with a higher score indicating higher acceptability of the intervention. The intervention will be considered acceptable if ≥ 70% of participants rate the intervention as acceptable, as indicated by a total score \>3.

    Through study completion, up to 12 weeks

Secondary Outcomes (9)

  • Difficulties in Emotion Regulation- Short Form Scale

    Baseline to post-intervention, up to 11 weeks

  • Emotion Regulation Behaviors Scale (ERBS-R)

    Baseline to post-intervention, up to 11 weeks

  • Implicit Theories of Emotion Scale- Child Version (ITES-C)

    Baseline to post-intervention, up to 11 weeks

  • Affect Dysregulation Scale (ADS)

    Baseline to post-intervention, up to 11 weeks

  • Early Adolescent Temperament Questionnaire (EATQ-R select subscales)

    Baseline to post-intervention, up to 11 weeks

  • +4 more secondary outcomes

Study Arms (1)

The T1D Talks Virtual Group Intervention for Teens and Tweens with T1D

EXPERIMENTAL

Experimental: The T1D Talks Group Intervention. This is the intervention, as this is a proof of concept pilot study, we will only have an intervention arm.

Behavioral: The T1D Talks: A Virtual Group for Teens and Tweens with T1D

Interventions

The T1D Talks intervention is an 11 session, virtual (online), group intervention. The T1D Talks intervention teaches developmentally appropriate emotion regulation (ER) skills and facilitates practicing these skills via role-plays and in-session experiences that are meant to elicit strong emotions. The investigators adapted the content and situations of an established intervention to be relevant for youth with T1D (e.g., practicing ER skills while role playing situations like telling parents about high blood glucose numbers or telling a coach about needing to take a time out from a game because of a low blood glucose level). The intervention also provides basic diabetes education about risky situations (e.g., how physical activity can affect blood glucose).

The T1D Talks Virtual Group Intervention for Teens and Tweens with T1D

Eligibility Criteria

Age12 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • T1D for at least 1 year
  • the ability to read/write and converse in English
  • reliable internet connection and a virtual meeting capable device (tablet or laptop)

You may not qualify if:

  • a chronic medical condition that requires intensive daily management
  • a significant mental health or cognitive disability that would prevent them from participating

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours Children's Hospital, Florida

Orlando, Florida, 32827, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Emotional Regulation

Interventions

Polysorbates

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesSelf-ControlSocial BehaviorBehavior

Intervention Hierarchy (Ancestors)

Polyethylene GlycolsEthylene GlycolsGlycolsAlcoholsOrganic ChemicalsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Rachel Wasserman, PhD

    Western Michigan University Homer Stryker MD School Of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Model Details: 3 sequential trials of a novel behavioral intervention
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 23, 2025

First Posted

August 7, 2025

Study Start

February 15, 2024

Primary Completion

November 14, 2025

Study Completion

November 14, 2025

Last Updated

August 7, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The de-identified and cleaned, item-level spreadsheet data for all variables will be shared with other researchers (along with example quantifications and transformations from initial raw data) via deposit in the data sharing repositories. The rationale for sharing only cleaned data is to foster ease of data reuse. Aggregate survey datasets and summaries of debriefing sessions, containing no identifiers, data collection instruments, codebook and data dictionary, qualitative analysis protocols, and code and statistical analysis protocols will be freely available via the data sharing repository (below).

Time Frame
The investigators will share this data by May 2027, either within 6 months of publication or within 18 months of the conclusion of the funding period (November 14, 2025), if the study remains unpublished.
Access Criteria
Public use and restricted access study data and associated documentation will be made available to the research community free of charge through openICPSR, (https://www.openicpsr.org/openicpsr/) which is a self-publishing repository for social, behavioral, and health sciences research data.

Locations